BANK OF AMERICA CORP /DE/
BankPosition in RXRX — Recursion Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,532,742
+$1,867,474 QoQ
Shares Held
2,597,478
+4.0% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Sep 30, 2025CallValue
$1,464,000
CallShares
300,000
PutValue
$2,136,952
PutShares
437,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RXRX ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RXRX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,532,742 | 2,597,478 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,665,268 | 2,496,831 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,639,487 | 2,112,345 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,136,952 | 437,900 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $5,973,005 | 1,223,977 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,464,000 | 300,000 | Call | Defined | 2026-02-03 | |
| 2025-06-30 | $6,977,308 | 1,378,915 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $2,034,120 | 402,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $2,615,514 | 516,900 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,095,030 | 207,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $6,797,447 | 1,284,962 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,968,159 | 882,864 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $2,424,812 | 358,700 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $897,558 | 136,200 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $7,680,147 | 1,165,425 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,810,987 | 1,841,465 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,978,049 | 1,702,914 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,916 | 600 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $7,742,829 | 785,277 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,875,511 | 898,760 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $4,590 | 600 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $1,723,461 | 230,718 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,715,255 | 557,010 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,252,570 | 421,864 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,115,933 | 198,866 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $864,605 | 106,217 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $599,148 | 83,680 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,932,226 | 171,175 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $609,924 | 26,507 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $287,510 | 7,877 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||